Thea Pharma Inc. is the U.S. subsidiary of Théa. Its product offering is comprised of a portfolio of seven leading eye-care products that are regulated or approved by the U.S. FDA, including Zioptan®, AcellFX™, Cosopt®, Cosopt® PF, Azasite®, Akten®, and Betimol®, iVIZIA dry-eye drops and eyelid hygiene products, and IYUZEH™. | Théa offers its technology and innovative preservative-free products to the US consumer under the iVIZIA brand of products—with iVIZIA lubricant eye drops as the foundation of the product line and formulated to cover the spectrum of dry eye relief. After its founding in 1994, Laboratories Théa was among the first eye care companies to introduce preservative-free products. Today, Laboratories Théa continues its pursuit of solutions that are more efficacious, more ergonomic, and safer.
Teradata
Teradata empowers healthcare with autonomous AI + the Healthcare Intelligence Framework to deliver trusted, context‑aware insights at scale. Our platform reduces readmissions, improves efficiency, and supports personalized care, without handling PHI, providing secure, governed, and measurable innovation across any environment.
Teqfocus Consulting LLC
Teqfocus is a Data and AI services company dedicated to helping healthcare organizations enhance patient care and operational efficiency through AI-driven insights and intelligent automation. At HIMSS25, we will showcase our expertise in workflow automation, Agentic AI, predictive analytics, FHIR-based interoperability, and cloud innovation—empowering healthcare organizations with real-time insights and personalized patient engagement while ensuring HIPAA and HITRUST compliance. As a trusted partner of Salesforce, AWS, Snowflake, Databricks, GCP, and Azure, we help healthcare leaders accelerate digital transformation and future-proof their technology investments. | Teqfocus is a global Data and AI consultancy that turns technology promise into measurable business outcomes. With deep-rooted expertise across Healthcare, Life Sciences, Insurance, and Hi-Tech, we help organizations move from AI roadmaps to real-world impact in weeks, not months. At VIVE 2026, we are showcasing how our intelligent automation and industry-specific accelerators bridge the gap between complex data and clinical efficiency.
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients across several therapeutic categories, starting with eye care. Their lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA-approved in the United States for the treatment of Demodex blepharitis. Learn more at TarsusRx.com.
Takeda Development Center Americas
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. www.takeda.com
Takeda Pharmaceuticals
Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. www.takeda.com